Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Database on blood and marrow stem cell transplants now available online

16.02.2004


The National Institute of Allergy and Infectious Diseases (NIAID), the National Library of Medicine (NLM) and the National Center for Biotechnology Information (NCBI), components of the National Institutes of Health (NIH), today launched the first public database of results from clinical blood and marrow stem cell transplants involving unrelated donors. Accessible at http://www.ncbi.nih.gov/mhc, this centralized resource provides genetic as well as age, gender and ethnicity data on more than 1,300 transplant donors and recipients from around the world.



The database is scheduled to be unveiled at the 2004 Tandem Bone Marrow Transplant Meetings in Orlando, FL. See http://www.asbmt.org/A/annual.asp?ID=1 for the meeting agenda.

With the availability of this new database, researchers can generate and test hypotheses on the role of donor matching in blood and marrow stem cell transplants. The database also provides survival rates of people who received cell grafts, helping doctors and their patients evaluate the potential risks and benefits of transplantation in treating disorders such as leukemia.


"This important new resource will make it easier for physicians to predict outcomes of blood and marrow stem cell transplants and to tailor therapies to the specific needs of their patients," says Anthony S. Fauci, M.D., director of NIAID.

"This effort is part of a long-range plan at NIAID to develop and disseminate genetic tools that provide greater predictive value for donor matching than current methods," says Daniel Rotrosen, M.D., director of NIAID’s Division of Allergy, Immunology and Transplantation.

The database contains scientific and clinical data on the relationship between major histocompatibility complex (MHC) genes and transplantation. Human MHC genes encode molecules on the surface of cells commonly known as human leukocyte antigens or HLA. These molecules alert the immune system to the presence of anything foreign in the body. MHC genes vary widely throughout the general population, so blood and marrow stem cells from one person may be rejected when transplanted into a recipient who does not closely match the donor’s MHC type.

The database allows scientists and physicians to search for information in a variety of ways. For example, a doctor can look for the results of transplants involving a recipient with a given set of MHC genes and an unrelated donor with another set of MHC genes.

"The widespread availability of clinical transplant results may help researchers recognize the limits of MHC mismatching," says Effie Wang Petersdorf, M.D., professor at the University of Washington School of Medicine and Member of the Fred Hutchinson Cancer Research Center, who leads the team of researchers and clinicians contributing transplant data to the project. "If we know which MHC mismatches may be tolerable, it may increase the use of transplantation as a curative therapy for patients who do not have a matched donor."

To ensure patient and donor privacy, none of the clinical information in the database contains personal identifiers such as birth dates. The available data include patient and donor MHC types, ethnicity, age and gender as well as the description of the transplant, the disease diagnosis and the number of days the recipient survived after the transplant.

This transplant database is part of a broader MHC database maintained by NCBI, and part of a larger effort supported by NIAID. The MHC database presents information from the International Histocompatibility Working Group in Hematopoietic Cell Transplantation, an effort spearheaded by NIAID with additional support from the Juvenile Diabetes Research Foundation; other NIH components, including the National Cancer Institute, the National Human Genome Research Institute, and the National Institute of Diabetes and Digestive and Kidney Diseases; and the Centers for Disease Control and Prevention.


###
NIAID, NLM and NCBI are components of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies.

Press releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

Paul Williams | EurekAlert!
Further information:
http://www.ncbi.nih.gov/mhc,
http://www.asbmt.org/A/annual.asp?ID=1
http://www.niaid.nih.gov/

More articles from Health and Medicine:

nachricht Candidate Ebola vaccine still effective when highly diluted, macaque study finds
21.10.2019 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Autism spectrum disorder risk linked to insufficient placental steroid
21.10.2019 | Children's National Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Solving the mystery of quantum light in thin layers

A very special kind of light is emitted by tungsten diselenide layers. The reason for this has been unclear. Now an explanation has been found at TU Wien (Vienna)

It is an exotic phenomenon that nobody was able to explain for years: when energy is supplied to a thin layer of the material tungsten diselenide, it begins to...

Im Focus: An ultrafast glimpse of the photochemistry of the atmosphere

Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have explored the initial consequences of the interaction of light with molecules on the surface of nanoscopic aerosols.

The nanocosmos is constantly in motion. All natural processes are ultimately determined by the interplay between radiation and matter. Light strikes particles...

Im Focus: Shaping nanoparticles for improved quantum information technology

Particles that are mere nanometers in size are at the forefront of scientific research today. They come in many different shapes: rods, spheres, cubes, vesicles, S-shaped worms and even donut-like rings. What makes them worthy of scientific study is that, being so tiny, they exhibit quantum mechanical properties not possible with larger objects.

Researchers at the Center for Nanoscale Materials (CNM), a U.S. Department of Energy (DOE) Office of Science User Facility located at DOE's Argonne National...

Im Focus: Novel Material for Shipbuilding

A new research project at the TH Mittelhessen focusses on the development of a novel light weight design concept for leisure boats and yachts. Professor Stephan Marzi from the THM Institute of Mechanics and Materials collaborates with Krake Catamarane, which is a shipyard located in Apolda, Thuringia.

The project is set up in an international cooperation with Professor Anders Biel from Karlstad University in Sweden and the Swedish company Lamera from...

Im Focus: Controlling superconducting regions within an exotic metal

Superconductivity has fascinated scientists for many years since it offers the potential to revolutionize current technologies. Materials only become superconductors - meaning that electrons can travel in them with no resistance - at very low temperatures. These days, this unique zero resistance superconductivity is commonly found in a number of technologies, such as magnetic resonance imaging (MRI).

Future technologies, however, will harness the total synchrony of electronic behavior in superconductors - a property called the phase. There is currently a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International Symposium on Functional Materials for Electrolysis, Fuel Cells and Metal-Air Batteries

02.10.2019 | Event News

NEXUS 2020: Relationships Between Architecture and Mathematics

02.10.2019 | Event News

Optical Technologies: International Symposium „Future Optics“ in Hannover

19.09.2019 | Event News

 
Latest News

Fraunhofer LBF and BAM develop faster procedure for flame-retardant plastics

21.10.2019 | Materials Sciences

For EVs with higher range: Take greater advantage of the potential offered by lightweight construction materials

21.10.2019 | Materials Sciences

Benefit and risk: Meta-analysis draws a heterogeneous picture of drug-coated balloon angioplasty

21.10.2019 | Medical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>